IMC Chicago’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $201M | Buy |
824,200
+42,500
| +5% | +$9.9M | 0.07% | 174 |
|
|
2025
Q4 | $162M | Buy |
781,700
+46,400
| +6% | +$9.18M | 0.06% | 199 |
|
|
2025
Q3 | $136M | Sell |
735,300
-53,800
| -7% | -$9.22M | 0.05% | 209 |
|
|
2025
Q2 | $121M | Sell |
789,100
-125,700
| -14% | -$19.3M | 0.05% | 196 |
|
|
2025
Q1 | $152M | Buy |
914,800
+221,000
| +32% | +$34.6M | 0.09% | 124 |
|
|
2024
Q4 | $100M | Buy |
693,800
+167,200
| +32% | +$25.9M | 0.05% | 209 |
|
|
2024
Q3 | $85.3M | Sell |
526,600
-50,500
| -9% | -$8.05M | 0.05% | 204 |
|
|
2024
Q2 | $84.3M | Buy |
577,100
+125,400
| +28% | +$18.7M | 0.05% | 195 |
|
|
2024
Q1 | $71.5M | Buy |
451,700
+21,800
| +5% | +$3.47M | 0.04% | 190 |
|
|
2023
Q4 | $67.4M | Sell |
429,900
-46,000
| -10% | -$7.05M | 0.05% | 202 |
|
|
2023
Q3 | $74.1M | Sell |
475,900
-16,100
| -3% | -$2.66M | 0.07% | 144 |
|
|
2023
Q2 | $81.4M | Buy |
492,000
+146,800
| +43% | +$23.7M | 0.07% | 123 |
|
|
2023
Q1 | $53.5M | Buy |
345,200
+83,900
| +32% | +$13.5M | 0.06% | 159 |
|
|
2022
Q4 | $46.2M | Sell |
261,300
-5,300
| -2% | -$915K | 0.07% | 171 |
|
|
2022
Q3 | $43.6M | Buy |
266,600
+73,400
| +38% | +$12.4M | 0.06% | 157 |
|
|
2022
Q2 | $34.3M | Sell |
193,200
-6,300
| -3% | -$1.12M | 0.05% | 183 |
|
|
2022
Q1 | $35.4M | Sell |
199,500
-18,100
| -8% | -$3.08M | 0.04% | 232 |
|
|
2021
Q4 | $37.2M | Sell |
217,600
-417,500
| -66% | -$68.4M | 0.03% | 259 |
|
|
2021
Q3 | $103M | Buy |
635,100
+365,100
| +135% | +$62.3M | 0.11% | 92 |
|
|
2021
Q2 | $44.5M | Buy |
270,000
+46,400
| +21% | +$7.68M | 0.05% | 184 |
|
|
2021
Q1 | $36.7M | Buy |
223,600
+7,100
| +3% | +$1.15M | 0.05% | 186 |
|
|
2020
Q4 | $34.1M | Buy |
216,500
+60,100
| +38% | +$8.87M | 0.04% | 178 |
|
|
2020
Q3 | $23.3M | Sell |
156,400
-8,900
| -5% | -$1.32M | 0.04% | 177 |
|
|
2020
Q2 | $23.2M | Buy |
165,300
+4,800
| +3% | +$699K | 0.05% | 140 |
|
|
2020
Q1 | $21M | Buy |
160,500
+65,400
| +69% | +$9.28M | 0.04% | 135 |
|
|
2019
Q4 | $13.9M | Sell |
95,100
-1,000
| -1% | -$136K | 0.04% | 175 |
|
|
2019
Q3 | $12.4M | Sell |
96,100
-11,500
| -11% | -$1.52M | 0.04% | 153 |
|
|
2019
Q2 | $15M | Sell |
107,600
-26,800
| -20% | -$3.71M | 0.05% | 123 |
|
|
2019
Q1 | $18.8M | Sell |
134,400
-7,700
| -5% | -$1.03M | 0.07% | 82 |
|
|
2018
Q4 | $18.3M | Buy |
+142,100
| New | +$19.8M | 0.06% | 78 |
|
Other funds holding JNJ
VCM
VPM
IMC Chicago's JNJ Position: Q1 2026 in Review
IMC Chicago sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 69,404 shares — an estimated $16.2M sold.
IMC Chicago first reported a position in JNJ in Q4 2019 and held it in 5 quarters. The position peaked at $14.4M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- IMC Chicago reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- IMC Chicago sold 69,404 Johnson & Johnson shares in Q1 2026, an estimated $16.2M.
- IMC Chicago first reported a position in Johnson & Johnson in Q4 2019 and held it in 5 quarters.
- IMC Chicago's Johnson & Johnson position peaked at $14.4M in Q4 2025.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.